Quinolizidines as Novel SARS-CoV-2 Entry Inhibitors

COVID-19, caused by the highly transmissible severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has rapidly spread and become a pandemic since its outbreak in 2019. We have previously discovered that aloperine is a new privileged scaffold that can be modified to become a specific antivira...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Li, Zhu, Lei, Xie, Hua, Goodwin, Jeffery Shawn, Rana, Tanu, Xie, Lan, Chen, Chin-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455918/
https://www.ncbi.nlm.nih.gov/pubmed/36077056
http://dx.doi.org/10.3390/ijms23179659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455918/
https://www.ncbi.nlm.nih.gov/pubmed/36077056
http://dx.doi.org/10.3390/ijms23179659

Ejemplares similares